drugset / Trial / NCT06569394
A Study of Cannabidiol in Young Adult Cannabis Users
Phase 2
Recruiting
200 enrolled
University of Colorado, Denver
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
The investigators will study the harm-reducing effect of hemp-derived CBD in non-treatment-seeking emerging adults who use cannabis regularly. The study will use a novel naturalistic cannabis administration approach, which examines ecologically valid cannabis use utilizing a mobile lab setting to assess the effects of the cannabis products the participants regularly use. The investigators will recruit a sample of emerging adults, half of whom primarily use flower products and half of whom primarily use concentrate products. Individuals will be randomly assigned to hemp-derived CBD or placebo.
Timeline
- Start
- 2024-12-09
- Primary completion
- 2028-06-30
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabidiol | Other / unclassified | 400 mg | Oral |